Product Information
BANZEL 400 MG TABLET is a brand product labeled by Eisai Inc., priced at $25.1954 per EA under NDC 62856058352. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 14, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the rufinamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Eisai Inc.NDC
62856058352
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RUFINAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021911FDA Approved
11/14/2008
TE Code
AB
On Market Since
11/14/2008
Price Statistics
The NADAC for BANZEL 400 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 155.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $25.1954 per EA |
|---|---|
| All-time high | $25.6555 (Feb 14, 2024) |
| All-time low | $9.8717 (Nov 28, 2013) |
| 52-week high | $25.3162 |
| 52-week low | $25.1954 |
| Median price | $24.2748 |
| Average price | $21.4162 |
| Largest weekly change | +9.9% (Feb 4, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BANZEL 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BANZEL 400 MG TABLET, manufactured by Eisai Inc., is $25.1954 per EA (NDC 62856058352), effective Aug 19, 2026.
How has the price of BANZEL 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for BANZEL 400 MG TABLET has risen 155.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BANZEL 400 MG TABLET?
Since Nov 28, 2013, the NADAC for BANZEL 400 MG TABLET has ranged from a low of $9.8717 (Nov 28, 2013) to a high of $25.6555 (Feb 14, 2024), with a median of $24.2748 per EA.
Are there cheaper alternatives to BANZEL 400 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RUFINAMIDE 400 MG TABLET, is $1.4532 per EA — about 94% below BANZEL 400 MG TABLET.
Who manufactures BANZEL 400 MG TABLET?
BANZEL 400 MG TABLET (NDC 62856058352) is labeled by Eisai Inc., and CMS classifies it as a brand product.